Systematic screening for metabolic syndrome in consumers with severe mental illness: Feature Article

International Journal of Mental Health Nursing

Volumn 18, Issue 2, 2009, Pages 144-150

  Brunero, Scott ^a   Lamont, Scott ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Metabolic syndrome; Physical health; Screening; Severe mental illness

Indexed keywords

ARTICLE; FITNESS; HEALTH STATUS; HOSPITALIZATION; HUMAN; MASS SCREENING; MENTAL DISEASE; METABOLIC SYNDROME X; METHODOLOGY; PREVALENCE; PSYCHIATRIC NURSING; PSYCHOLOGICAL ASPECT;

HEALTH STATUS; HUMANS; MASS SCREENING; MENTAL DISORDERS; METABOLIC SYNDROME X; PHYSICAL FITNESS; PREVALENCE; PSYCHIATRIC NURSING; SEVERITY OF ILLNESS INDEX;

EID: 62249218243     PISSN: 14458330     EISSN: 14470349     Source Type: Journal    
DOI: 10.1111/j.1447-0349.2009.00595.x     Document Type: Article

References (41)

1. Ahmed, M., Hussain, I., O'Brien, S. M., Dineen, B., Griffin, D. McDonald, C. (2008). Prevalence and associations of the metabolic syndrome among patients prescribed clozapine. Irish Journal of Medical Sciences, 177, 205 210.
2. American Diabetes Association & American Psychiatric Association (2004). Consensus development conference on antipsychotics drugs and obesity and diabetes. Diabetes Care, 27, 396 601.
3. Bowling, A. (2002). Research Methods in Health, 2nd edn. Buckingham, Philadelphia, PA : Open University Press.
4. Braveman, P. Tarimo, E. (1996). Health screening development and equity. Journal of Public Health Policy, 17, 14 27.
5. Brunero, S., Lamont, S. Fairbrother, G. (2009). Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia. Archives of Psychiatric Nursing. [Cited 27 Jan 2009]. Available from: URL: http://www.psychiatricnursing.org/article/50883-9417(08)00137-4/ abstract
6. Connolly, M. Kelly, C. (2005). Lifestyle and physical health in schizophrenia. Advances in Psychiatric Treatment, 11, 125 132.
7. Consultation Liaison Special Interest Group (2005). Consultation Liaison Special Interest Group Cited 8 Dec 2008]. Available from: URL: http://www.acmhn.org/
8. Council of Europe 1994). Committee of Ministers, Recommendations on Screening as a Tool of Preventative Medicine. Council of Europe. No. R(94), 11, October 10.
9. De Hert, M., Van Eyck, D. De Nayer, A. (2006). Metabolic abnormalities associated with second generation antipsychotics: Fact or fiction? Development of guidelines for screening and monitoring. International Clinical Psychopharmacology, 21 (Suppl. 2 S11 S15.
10. Elsom, S., Happell, B. Manias, E. (2005). Mental health nurse practitioner: Expanded or advanced? International Journal of Mental Health Nursing, 14, 181 186.
11. Emerson, E. (2003). Prevalence of psychiatric disorders in children and adolescents with and without intellectual disability. Journal of Intellectual Disability Research, 47, 51 58.
12. Gafoor, M. (2001). The co-existence of psychiatric disorders and substance misuse: Working with dual diagnosis patients. Journal of Advanced Nursing, 27, 497 502.
13. Gardner, A. Gardner, G. (2005). A trial of nurse practitioner scope of practice. Journal of Advanced Nursing, 49, 135 145.
14. Hanson, L., Pettitt, J., Bennett, H. et al. (1995). Familial relationships between obesity and NIDDM. Diabetes, 44, 418 422.
15. Hoffman, L., Nolan, C., Wilson, J. D., Oats, J. N. Simmons, D. (1998). Gestational diabetes mellitus - management guidelines. Medical Journal of Australia, 169, 93 97.
16. Howard, P., El-Mallakh, P., Rayens, M. K. Clark, J. J. (2007). Co-morbid medical illness and perceived general health among adult recipients of Medicaid mental health services. Issues in Mental Health Nursing, 28, 255 274.
17. Hussein-Rassool, G. (2007). Dual Diagnosis Nursing: Nursing Management. London : Blackwell Publishing.
18. International Diabetes Federation (2007). Worldwide Definition of the Metabolic Syndrome Cited 14 Feb 2008]. Available from: URL: http://www.idf.org/ home/index.cfm?unode=1120071E-AACE-41D2-9FA0-BAB6E25BA072
19. Katon, W., Von Korff, M., Lin, E. Simon, G. (2001). Rethinking practitioner in chronic illness: The specialist, primary care physician, and the practice nurse. General Hospital Psychiatry, 23, 138 144.
20. Kousta, E., Tolis, G. Franks, S. (2005). Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences. Hormones, 4, 133 147.
21. Lambert, T. Chapman, L. (2005). Diabetes, Psychotic Disorders and Antipsychotic Therapy, a Consensus Statement. Members for the Australian Consensus Panel for Diabetes, Psychotic Disorders and Antipsychotic Therapy. Sydney : Eli-Lilly Australia.
22. Lamberti, J., Olson, D., Crilly, J. et al. (2006). Prevalence of the metabolic syndrome among patients receiving clozapine. American Journal of Psychiatry, 163, 1273 1275.
23. Llorente, M. D. Urrutia, V. (2006). Diabetes, psychiatric disorders, and the metabolic effects of antipsychotic medications. Clinical Diabetes, 24, 18 24.
24. Marder, R., Essock, D., Miller, A. et al. (2004). Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry, 161, 1334 1349.
25. Mental Health Consultation Liaison Nurses Association (2008). Mental Health Consultation Liaison Nurses Association Cited 8 Dec 2008]. Available from: URL: http://www.mhclna.org.au/
26. Muir-Cochrane, E. Wand, T. (2005). Contemporary Issues in Risk Assessment and Management in Mental Health. Greenacres, SA : Australian and New Zealand College of Mental health Nurses Inc.
27. Norris, P., Nichols, C., Caspersen, R. et al. (2002). The effectiveness of disease and case management for people with diabetes. A systematic review. American Journal of Preventive Medicine, 22, 15 38.
28. Oortwijn, W., Banta, D. H. Cranovsky, R. (2001). Introduction: Mass screening, health technology assessment and health policy in some European countries. International Journal of Technology Assessment in Health Care, 17, 269 274.
29. Osborn, D. P. (2001). The poor physical health of people with mental illness. Western Journal of Medicine, 175, 329 332.
30. Phelan, M., Stradins, L., Amin, D. et al. (2004). The Physical Health Check: A tool for mental health workers. Journal of Mental Health, 13, 277 284.
31. Poulin, M., Cortese, L., Williams, R., Wine, N. Mcintyre, R. (2005). Atypical antipsychotics in psychiatric practice: Practical implications for clinical monitoring. Canadian Journal of Psychiatry, 50, 555 562.
32. Sacks, F. M. (2004). Metabolic syndrome: Epidemiology and consequences. Journal of Clinical Psychiatry, 65 (Suppl. 18 3 12.
33. Salsberry, P., Corwin, E. Reagan, P. (2007). A complex web of risks for metabolic syndrome: Race/ethnicity, economics, and gender. American Journal of Preventive Medicine, 33, 114 120.
34. Schizophrenia and Diabetes Expert Consensus Meeting (2003). Consensus summary, 3-4 October. British Journal of Psychiatry, 184 (S47 112 114.
35. Shaw, C. Costain, D. (1989). Guidelines for medical audit: Seven principles. British Medical Journal, 19, 498 499.
36. Straker, D., Correll, C., Kramer-Ginsberg, E. et al. (2005). Cost effective screening for the metabolic syndrome in patients treated with second generation antipsychotic medications. American Journal of Psychiatry, 162, 1217 1221.
37. Usher, K., Foster, K. Park, T. (2006). The metabolic syndrome and schizophrenia: the latest evidence and nursing guidelines for management. Journal of Psychiatric and Mental Health Nursing, 13, 730 734.
38. Wand, T. Murray, L. (2008). Lets get physical. International Journal of Mental Health Nursing, 17, 363 379.
39. Wilson, J. M. G. Jungner, G. (1968). Principles and Practice of Screening for Disease, Public Health Paper No. 34. Geneva : World Health Organization.
40. Wright, C. E., O'Donnell, K., Brydon, L., Wardle, J. Steptoe, A. (2007). Family history of cardiovascular disease is associated with cardiovascular responses to stress in healthy young men and women. International Journal of Psychophysiology, 63, 275 282.
41. Wu, R., Zhao, J., Jin, H. et al. (2008). Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain a randomized controlled trial. JAMA, 299, 185 193.